Mia's Feed
Medical News & Research

Decline in Community Pharmacy Availability in deprived Areas of England

Decline in Community Pharmacy Availability in deprived Areas of England

Share this article

Research shows that community pharmacy availability in England is decreasing, especially in economically deprived areas, risking increased health inequalities and reduced access to vital healthcare services.

2 min read

Recent research highlights a concerning decline in the availability of community pharmacies across England, particularly impacting deprived areas with poorer health outcomes. A study conducted by researchers from Newcastle University, the University of Manchester, and Health Equity North analyzed data from 2014 to 2023 and found that while over 90% of the population lives within a 20-minute walk to a pharmacy, the overall number of pharmacies has decreased from 1.6 to 1.5 per 10,000 people. Notably, the most deprived regions experienced a 65% higher likelihood of losing their local pharmacy compared to wealthier areas.

Pharmacies are vital components of the healthcare system, offering accessible services such as smoking cessation programs, contraceptive support, hypertension screening, and flu vaccinations. Despite their importance, recent funding cuts and closures have led to increased health inequalities. The study revisited the 'positive pharmacy care law,' which suggests that deprived communities should have better access to local pharmacies. Although this law remains valid, its influence has lessened over time, and access is shrinking especially in the most vulnerable areas.

Numerical analysis revealed that in 2014, deprived areas had 2.28 pharmacies per 10,000 people, which declined to 2.01 in 2023. Conversely, the least deprived areas saw a reduction from 1.37 to 1.33 per 10,000 people. The decline was most significant in urban regions, with an 8.2% decrease in pharmacy availability. These trends mean more residents in disadvantaged communities will rely on fewer pharmacies, limiting access to essential clinical services.

Experts warn that ongoing funding reductions threaten the capacity of community pharmacies to deliver extended healthcare services, which may lead to further health disparities. Reinvestment in pharmacy networks is vital to address current challenges and support the delivery of public health initiatives in underserved areas.

As lead author Eman Zied Abozied emphasized, without adequate funding and strategic support, the strain on pharmacies serving high-need communities could intensify, potentially widening existing health inequalities. Health authorities are urged to consider increased investment to sustain pharmacy services and improve healthcare equity across England.

Stay Updated with Mia's Feed

Get the latest health & wellness insights delivered straight to your inbox.

How often would you like updates?

We respect your privacy. Unsubscribe at any time.

Related Articles

Heart disease and weight gain increase breast cancer risk after menopause

New research shows that weight gain and cardiovascular disease significantly increase breast cancer risk in postmenopausal women, underscoring the importance of maintaining a healthy weight and heart health.

Research Shows Seasonal Flu Immunity Offers Protection Against Severe Bird Flu in Ferrets

New research indicates that immunity to seasonal influenza, especially H1N1, offers protection against severe H5N1 bird flu in ferrets, shedding light on milder human cases despite ongoing outbreaks.

Shorter Treatment Regimen Shows Promise for Some Patients with Drug-Resistant Tuberculosis

A groundbreaking study reveals that a shorter, targeted treatment regimen can be effective for some patients with pre-extensively drug-resistant tuberculosis, paving the way for more personalized therapies.

Innovative Blood Test Combining Two Methods Boosts Early Detection of Colorectal Cancer

A new blood test combining immunoprecipitation and multiplex digital PCR offers high accuracy in early colorectal cancer detection with minimal blood volume, promising to improve screening and patient outcomes.